Access to Pharmaceuticals > The ATP consortium > Oswaldo Cruz Foundation (FIOCRUZ)

Oswaldo Cruz Foundation (FIOCRUZ)

Fiocruz has its presence throughout Brazil, through its support to the Sistema Único de Saúde (Unified Health System, the Brazilian public health system), and has significant influence on Brazil’s public health policy-making, its research activities, its scientific expeditions, and the reach of its health services and products. Inaugurated on May 25, 1900 under the name of Federal Serotherapy Institute, Fiocruz was given the mission of fighting the great problems of public health in Brazil. Therefore, Fiocruz became a think tank concerned with the Brazilian reality and experimental medicine. Today the institution is responsible for a range of activities which include research development; highly-regarded hospital and ambulatory care services; production of vaccines, drugs, reagents, and diagnostic kits; education and training of human resources; information and communication in the area of health, science and technology; quality control of products and services, and the implementation of social programs. It has over 7,500 employees and health professionals with different levels of involvement, a workforce proud of being at the service of life. Fiocruz is based at a 800,000-square meter campus in Manguinhos, a neighborhood in the northern part of the city of Rio de Janeiro. Around the three historical buildings of the old Federal Serotherapy Institute – the Moorish Pavilion, the Clock Pavilion and the Mews -, are located ten of Fiocruz’s thirteen technical-scientific units and all the technical and administrative support units. Another five units are located in Rio de Janeiro, Belo Horizonte, Salvador, Recife and Manaus.

Partners at this institution:

Prof. Carlos Morel

Prof. Carlos Morel

Prof. Claudia Chamas

Prof. Claudia Chamas